Results from the Madison Memory Study
We report here on a double-blind, placebo controlled study designed to assess the effect of a apoaequorin supplement, compared to placebo, on specific areas of cognitive functioning using
quantitative, computerized assessments. In a recent double-blind, placebo-controlled trial, older adults taking an apoaequorin supplement reported improvements in memory.*
A total of 218 adults, aged 40 to 91 years, who had self-reported mild memory concerns associated with aging were randomly assigned to receive a 90 day supply of either apoaequorin 10 mg daily or a matched placebo. Participants were tested at predetermined time points using computer-based assessments from CogState Ltd (www.cogstate.com). Changes on specific assessments of cognitive function were measured at various time points during the study.